Drug Company Releases Medicine for 7-Year-Old Cancer Patient
- 10 years ago
Pharmaceutical company Chimerix has announced that they will release a new drug for trial to a seven year old boy with cancer.
Pharmaceutical company Chimerix has announced that they will release a new drug for trial to a seven year old boy with cancer, who will be the first of 20 people to receive the treatment.
Josh Hardy was diagnosed with a rare kind of kidney cancer when he was only 9 months old.
As he got older, the cancer spread to other parts of his body like the thymus, lung, and bone marrow, but he was able to fight it off every time.
Getting a bone marrow transplant left Josh with a weakened immune system, and he was diagnosed with an adenovirus, which has left him in the intensive care unit of the St. Jude Children’s Research Hospital in Memphis, Tennessee.
Previously, Chimerix had refused to give Josh the drug called brincidofovir, saying that allowing the drug to be released to a few patients would slow down the process of getting it on the market.
The Food and Drug Administration’s policy allows for patients with life threatening diseases to request experimental drug treatments, but drug companies reportedly often refuse to release certain drugs.
Pharmaceutical company Chimerix has announced that they will release a new drug for trial to a seven year old boy with cancer, who will be the first of 20 people to receive the treatment.
Josh Hardy was diagnosed with a rare kind of kidney cancer when he was only 9 months old.
As he got older, the cancer spread to other parts of his body like the thymus, lung, and bone marrow, but he was able to fight it off every time.
Getting a bone marrow transplant left Josh with a weakened immune system, and he was diagnosed with an adenovirus, which has left him in the intensive care unit of the St. Jude Children’s Research Hospital in Memphis, Tennessee.
Previously, Chimerix had refused to give Josh the drug called brincidofovir, saying that allowing the drug to be released to a few patients would slow down the process of getting it on the market.
The Food and Drug Administration’s policy allows for patients with life threatening diseases to request experimental drug treatments, but drug companies reportedly often refuse to release certain drugs.